Headshot of André Fenton.

André Fenton

Professor, New York University
Contributing editor, The Transmitter

André Fenton is professor of neural science and director of the Center for Neural Science at New York University. He investigates the molecular, neural, behavioral and computational aspects of memory. He studies how brains store experiences as memories, how they learn to learn, and how knowing activates relevant information without activating what is irrelevant. These investigations are founded in how the brain computes knowledge of space, particularly the locations and directions that are the framework for experience. His investigations integrate across levels of biological organization; his research uses genetic, molecular, electrophysiological, imaging, behavioral, engineering and theoretical methods. This computational psychiatry research is helping to elucidate mental dysfunction in diverse conditions, including schizophrenia, autism, and depression.

Fenton founded BioSignal Group, Corp., which commercialized an FDA-approved portable, wireless and easy-to-use platform for recording EEGs in novel medical applications. He implemented a CPAP-oxygen-helmet treatment for COVID-19 in Nigeria and other low- and middle-income countries, and he develops information technology for the patient-centric coordination of behavioral health services that is desperately needed to equitably deliver care for mental health. Fenton hosted PBS’ “NOVA Wonders,” and he chairs the National Institute of Mental Health’s Board of Scientific Counselors.

Explore more from The Transmitter

Cell population in brainstem coordinates cough, new study shows

The work also adds to a growing body of evidence showing that mice, and their genetic toolbox, can be used to study cough.

By Calli McMurray
6 September 2024 | 5 min read
Capitol building
Spectrum Microphone

In updated U.S. autism bill, Congress calls for funding boost, expanded scope

The current Autism CARES Act sunsets in late September.

By Rachel Zamzow
5 September 2024 | 5 min listen
Illustration of ketamine blocking open ion channels in active NMDA receptors, quieting the cells and disrupting downstream signaling involved in depression.

Ketamine targets lateral habenula, setting off cascade of antidepressant effects

The drug’s affinity for overactive cells in the “anti-reward” region may help explain its rapid and long-lasting results.

By Olivia Gieger
4 September 2024 | 6 min read